Brief: Tivic Health Systems Q3 Net Income USD -2.596 Million
14/11/2025 21:30
Nov 14 (Reuters) - Tivic Health Systems Q3 operating expenses USD 2.338 million. Q3 revenue USD 146 thousand Q3 gross profit USD -145 thousand Q3 operating income USD -2.483 million Q3 basic EPS USD -1.97
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital